Last reviewed · How we verify
Use of BEPREVE (Bepotastine Besilate Ophthalmic Solution) 1.5% for Allergic Conjunctivitis and Contact Lenses
The purpose of this study is to assess if BEPREVE (bepotastine besilate ophthalmic solution) 1.5% will have an effect on contact lens wear in patients with contact lens intolerance due to allergic conjunctivitis.
Details
| Lead sponsor | Hom, Milton M., OD, FAAO |
|---|---|
| Phase | Phase 4 |
| Status | UNKNOWN |
| Enrolment | 24 |
| Start date | 2011-05 |
| Completion | 2011-11 |
Conditions
- Allergic Conjunctivitis
Interventions
- Bepotastine
Primary outcomes
- Questionnaire — 8 weeks
Contact lens comfort and wearing times (measured in hours)